Published online before print September 14, 2007

This Article Full Text Full Text (PDF) Supplemental Material All Versions of this Article: ajpath.2007.070021v1 171/5/1713    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Canault, M. Articles by Nalbone, G. Search for Related Content PubMed PubMed Citation Articles by Canault, M. Articles by Nalbone, G.

(American Journal of Pathology. 2007;171:1713-1723.)
© 2007 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2007.070021

Microparticles of Human Atherosclerotic Plaques Enhance the Shedding of the Tumor Necrosis Factor- Converting Enzyme/ADAM17 Substrates, Tumor Necrosis Factor and Tumor Necrosis Factor Receptor-1

Matthias Canault^*, Aurélie S. Leroyer, Franck Peiretti^*, Guy Lesèche, Alain Tedgui, Bernadette Bonardo^*, Marie-Christine Alessi^*, Chantal M. Boulanger and Gilles Nalbone^*

From INSERM, U626,^* Marseille; the Université de la Méditerranée, Marseille; INSERM, U689, Centre de Recherche Cardiovasculaire Lariboisière, Paris; and the Hôpital Beaujon, Clichy, France

Human atherosclerotic plaques express the metalloprotease tumor necrosis factor (TNF)- converting enzyme (TACE/ADAM-17), which cleaves several transmembrane proteins including TNF and its receptors (TNFR-1 and TNFR-2). Plaques also harbor submicron vesicles (microparticles, MPs) released from plasma membranes after cell activation or apoptosis. We sought to examine whether TACE/ADAM17 is present on human plaque MPs and whether these MPs would affect TNF and TNFR-1 cellular shedding. Flow cytometry analysis detected 12,867 ± 2007 TACE/ADAM17⁺ MPs/mg of plaques isolated from 25 patients undergoing endarterectomy but none in healthy human internal mammary arteries. Plaque MPs harbored mainly mature active TACE/ADAM17 and dose dependently cleaved a pro-TNF mimetic peptide, whereas a preferential TACE/ADAM17 inhibitor (TMI-2) and recombinant TIMP-3 prevented this cleavage. Plaque MPs increased TNF shedding from the human cell line ECV-304 overexpressing TNF (ECV-304_TNF), as well as TNFR-1 shedding from activated human umbilical vein endothelial cells or ECV-304_TNF cells, without affecting TNF or TNFR-1 synthesis. MPs also activated the shedding of the endothelial protein C receptor from human umbilical vein endothelial cells. All these effects were inhibited by TMI-2. The present study shows that human plaque MPs carry catalytically active TACE/ADAM17 and significantly enhance the cell surface processing of the TACE/ADAM17 substrates TNF, TNFR-1, and endothelial protein C receptor, suggesting that TACE/ADAM17⁺ MPs could regulate the inflammatory balance in the culprit lesion.

This article has been cited by other articles:

				G. Pasterkamp and D. de Kleijn Microparticles, Debris That Hurts J. Am. Coll. Cardiol., October 14, 2008; 52(16): 1312 - 1313. [Full Text] [PDF]

				M. M. Kavurma, N. Y. Tan, and M. R. Bennett Death Receptors and Their Ligands in Atherosclerosis Arterioscler. Thromb. Vasc. Biol., October 1, 2008; 28(10): 1694 - 1702. [Abstract] [Full Text] [PDF]